Skip to content

Use of ozone gas in treating muscle pain

A comparative assessment of clinical efficacy of Ozone Rectal Insufflation versus Intramuscular Injection among Fibromyalgia adult cases between 30-55 Years of age: An Open labelled clinical trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060721
Enrollment
60
Registered
2023-12-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M629- Disorder of muscle, unspecified

Interventions

Intervention1: Ozone Rectal Insufflation: Ozone Rectal Insufflation with 10 microgram of concentration and 150 ml of initial volume as a 1st dose Frequency- 1 in every 2 days for 30 days Route of Admi

Sponsors

National Institute of Naturopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Cases between 30-55 years 2. subjective symptoms associated with Fibromyalgia. Muscle Pain Weakness Generalized body pain 3. Ready to provide a voluntary informed consent.

Exclusion criteria

Exclusion criteria: Any case with Piles, Fistula or Hemorrhoids

Design outcomes

Primary

MeasureTime frame
The expected outcome of the research is reduction of the clinical sign and symptoms (such as pain, malaise).Timepoint: Baseline 2nd week 30 days

Secondary

MeasureTime frame
N/ATimepoint: N/A

Countries

India

Contacts

Public ContactDr Prakhar Saxena

National Institute of Naturopathy

dsathyanath@gmail.com9271286383

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026